OTSUKA AMERICA PHARMACEUTICALS, INC

ABILIFY ASIMTUFII

Manufacturer:

OTSUKA AMERICA PHARMACEUTICALS, INC

Abilify Asimtufii HCPCS:

J0402

HCPCS Code Descriptor:

Injection, aripiprazole (abilify asimtufii), 1 mg

Category:

J Code

Abilify Asimtufii NDCs:

59148-0114-80, 59148-0102-80

Primary Type:

Psychiatric

Generic/Specialty Status:

Single-Source

Route of Administration:

Intramuscular

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Abilify Asimtufii:

ABILIFY ASIMTUFII is a Psychiatric drug manufactured by OTSUKA AMERICA PHARMACEUTICALS, INC and administered via the Intramuscular route of administration. The J Code: J0402 is aligned to the drug ABILIFY ASIMTUFII.

Abilify Asimtufii is a type of atypical antipsychotic used to treat schizophrenia and bipolar I disorder in adults. It is given by extended-release injection once every two months. Abilify Asimtufii is thought to work balancing the levels of serotonin and dopamine in the brain.

ACCESS PRICING AND MORE BY REGISTERING

J0402 Added Date:

January 1, 2024

J0402 Effective Date:

January 1, 2024

J0402 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Abilify Asimtufii billing and coding information.
Our team did not identify a source for Abilify Asimtufii patient assistance information. Please reach out to our team if you feel that this is a mistake.
ABILIFY ASIMTUFII prescribing information can be found at the link below:
Information regarding ABILIFY ASIMTUFII’s side effects can be found at MedlinePlus